Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,800
Closed -$533K 739
2022
Q4
$533K Buy
7,800
+1,906
+32% +$121K ﹤0.01% 716
2022
Q3
$313K Sell
5,894
-4,159
-41% -$249K ﹤0.01% 822
2022
Q2
$631K Buy
10,053
+1,576
+19% +$96.6K ﹤0.01% 871
2022
Q1
$545K Buy
+8,477
New +$580K ﹤0.01% 877
2019
Q1
Sell
-31,339
Closed -$933K 336
2018
Q4
$933K Buy
+31,339
New +$989K 0.01% 334
2018
Q3
Sell
-19,029
Closed -$553K 377
2018
Q2
$553K Sell
19,029
-12,108
-39% -$368K 0.01% 345
2018
Q1
$932K Buy
+31,137
New +$1.01M 0.01% 277
2015
Q4
Sell
-25,806
Closed -$424K 291
2015
Q3
$424K Buy
+25,806
New +$501K 0.01% 351

Other funds holding BRKR

Ray Dalio's BRKR Position: Q1 2023 in Review

Ray Dalio sold out of Bruker (BRKR) in Q1 2023, closing a stake of 7,800 shares — an estimated $533K sold.

Ray Dalio first reported a position in BRKR in Q3 2015 and held it in 8 quarters. The position peaked at $933K in Q4 2018. 319 funds tracked by Wall St. Rank hold BRKR as of Q1 2023.

  • Ray Dalio reported no remaining Bruker position as of Q1 2023 after selling out during the quarter.
  • Ray Dalio sold 7,800 Bruker shares in Q1 2023, an estimated $533K.
  • Ray Dalio first reported a position in Bruker in Q3 2015 and held it in 8 quarters.
  • Ray Dalio's Bruker position peaked at $933K in Q4 2018.
  • 319 funds tracked by Wall St. Rank held Bruker as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.